Ετικέτες

Δευτέρα 8 Φεβρουαρίου 2021

Correcting Overt Thyroid Hypothyroidism Improves Some Dyslipidemias

xlomafota13 shared this article with you from Inoreader

showCoverImage?journalCode=

Clinical Thyroidology, Volume 33, Issue 2, Page 58-60, February 2021.
View on the web

Differentiated Thyroid Cancer Patients with Increased Thyroglobulin and Negative Radioiodine Scintigraphy Have Similar Long-Term Survival Whether or Not 18F-FDG–PET Imaging Is Used in Long-Term Monitoring

xlomafota13 shared this article with you from Inoreader

showCoverImage?journalCode=

Clinical Thyroidology, Volume 33, Issue 2, Page 92-95, February 2021.
View on the web

The Incidence of Overt Hyperthyroidism After Exposure to Iodinated Radiologic Contrast Media Is Extremely Low

xlomafota13 shared this article with you from Inoreader

showCoverImage?journalCode=

Clinical Thyroidology, Volume 33, Issue 2, Page 77-79, February 2021.
View on the web

What Do Hürthle Cells Mean in Thyroid Nodule Aspirates?

xlomafota13 shared this article with you from Inoreader

showCoverImage?journalCode=

Clinical Thyroidology, Volume 33, Issue 2, Page 83-86, February 2021.
View on the web

Effect of a Single Injection of Basic Fibroblast Growth Factor into the Vocal Folds: A 36-Month Clinical Study

xlomafota13 shared this article with you from Inoreader
A single injection of basic fibroblast growth factor (bFGF) into the vocal folds of patients with glottal insufficiency has been shown to be effective for a few years. However, the long-term therapeutic effect of a single injection of bFGF into the vocal folds has yet to be demonstrated. In this study, the therapeutic effect of a single injection of bFGF into the vocal folds was investigated over several years by monitoring patients for 36 months following this treatment.
View on the web

Sensitivity to Pulse Phase Duration as a Marker of Neural Health Across Cochlear Implant Recipients and Electrodes

xlomafota13 shared this article with you from Inoreader

10162.jpg

Abstract

In cochlear implants, loudness has been shown to grow more slowly with increasing pulse phase duration (PPD) than with pulse amplitude (PA), possibly due to "leaky" charge integration. This leakiness has been recently quantified in terms of "charge integration efficiency," defined as the log difference between the PPD dynamic range and PA dynamic range (both expressed in charge units), relative to a common threshold anchor. Such leakiness may differ across electrodes and/or test ears, and may reflect underlying neural health. In this study, we examined the across-site variation of charge integration in recipients of Cochlear© devices. PPD and PA dynamic ranges were measured relative to two threshold anchors with either a 25- or 50-microsecond PPD. Strength-duration functions, previously shown to relate to survival of spiral ganglion cells and peripheral processes, were compared to charge integration efficiency on selected electrodes. Results showed no si gnificant or systematic relationship between the across-site variation in charge integration efficiency and electrode position or threshold levels. Charge integration efficiency was poorer with the 50-μs threshold anchor, suggesting that greater leakiness was associated with larger PPD dynamic ranges. Poorer and more variable charge integration efficiency across electrodes was associated with longer duration of any hearing loss, consistent with the idea that poor integration is related to neural degeneration. More variable integration efficiency was also associated with poorer speech recognition performance across test ears. The slopes of the strength-duration functions at maximum acceptable loudness were significantly correlated with charge integration efficiency. However, the strength-duration slopes were not predictive of duration of any hearing loss or speech recognition performance in our participants. As such, charge integration efficiency may be a better candidate to measure leakiness in neural populations across the electrode array, as well as the general health of the auditory nerve in human cochlear implant recipients.

View on the web

Thyrotropin Receptor-Specific Lymphocytes in Adenovirus-TSHR-Immunized Native and Human Leukocyte Antigen-DR3-Transgenic Mice and in Graves' Disease Patient Blood

xlomafota13 shared this article with you from Inoreader

showCoverImage?journalCode=

Thyroid, Ahead of Print.
View on the web

Κυριακή 7 Φεβρουαρίου 2021

Type 2 diabetes mellitus increases peritonsillar abscess susceptibility: real-world evidence.

xlomafota13 shared this article with you from Inoreader
Related Articles

Type 2 diabetes mellitus increases peritonsillar abscess susceptibility: real-world evidence.

Clin Exp Otorhinolaryngol. 2021 Jan 14;:

Authors: Wu CL, Tsai MS, Lee TJ, Wang YT, Liu CY, Yang YH, Tsai YT, Hsu CM, Wu CY, Chang PJ, Chang GH

Abstract
Objectives: Type 2 diabetes mellitus (T2DM) is a risk factor for deep neck infection (DNI) and lead to complications and poor outcomes. Our study aims to investigate the risk, prognosis, and complications of peritonsillar abscess (PTA) in patients with T2DM.
Methods: We extracted data of patients newly diagnosed as having T2DM between January 2000 and December 2011 from Taiwan's National Health Insurance (NHI) Research Database. These patients were matched with patients without T2DM, and PTA incidence was compared between the both cohorts.
Results: In total, 67 852 patients with and 135 704 patients without T2DM were enrolled. PTA incidence was significantly higher in patients with T2DM (incidence rate ratio: 1.91, P < .001); moreover, PTA incidence was higher at 1 to 5 years after T2DM diagnosis than at <1 and >5 years after T2DM diagnosis. Cox regression analysis showed that patients with T2DM had an approximately 2-fold higher PTA risk (adjusted hazard ratio [aHR]: 1.89, P < .001). Patients with a higher adapted Diabetes Complications Severity Index (aDCSI) had higher PTA risk than those with a lower aDCSI (aHRs: 2.17 for aDCSI ≥ 1 [P = .006] and 1.81 [1.24-2.64] for aDCSI = 0 [P = .002]). T2DM patients with high aDCSI (≥1) had nonsignificantly longer hospitalization duration, higher DNI complication than did those with low aDCSI (=0).
Conclusion: In patients with T2DM, PTA incidence was relatively high, and it increased with T2DM severity. Moreover, diabetic patients diagnosed within 1 to 5 years should be careful about PTA infection and physicians should keep in mind that PTA prognosis was correlated with T2DM severity.

PMID: 33541035 [PubMed - as supplied by publisher]

View on the web

Sialendoscopy combined with transoral sialodochoplasty for treatment of parotid duct stenosis with megaduct.

xlomafota13 shared this article with you from Inoreader
Related Articles

Sialendoscopy combined with transoral sialodochoplasty for treatment of parotid duct stenosis with megaduct.

Clin Exp Otorhinolaryngol. 2021 Jan 14;:

Authors: Shin GC, Kim J, Lee SJ, Kang MS, Ahn SJ, Lim JY

Abstract
This study aimed to analyze the surgical outcomes of sialendoscopy combined with transoral sialodochoplasty for the treatment of patients with parotid duct stenosis with megaduct. This study included 13 patients with chronic obstructive sialadenitis caused by type 2 parotid duct stenosis who underwent transoral sialodochoplasty. All patients completed a three-point Likert-type rating scale at 3 months after surgery. Six (46.2%) glands showed complete resolution, and seven (53.8%) showed partial resolution of obstructive symptoms. Megaduct diameter between pre- and postoperative MR sialography significantly decreased after transoral sialodochoplasty (8.05 ± 2.67 vs. 4.15 ± 2.4, P = 0.028). Saliva excretion was improved after the transoral sialodochoplasty, as the distal ducts were visualized with a sialagogue postoperatively. Type 2 parotid duct stenosis can be successfully treated with sialendoscopy combined with sialodochoplasty. In cases of large megaduct, transoral sialo dochoplasty appears to offer benefits of reducing the diameter of dilated megaducts and improving salivary outflow.

PMID: 33541036 [PubMed - as supplied by publisher]

View on the web

Feasibility of Surgical Treatment for Laryngomalacia using Spontaneous Respiration Technique.

xlomafota13 shared this article with you from Inoreader
Related Articles

Feasibility of Surgical Treatment for Laryngomalacia using Spontaneous Respiration Technique.

Clin Exp Otorhinolaryngol. 2021 Jan 08;:

Authors: Cha H, Lee DY, Kim EH, Lee JH, Jang YE, Kim HS, Kwon SK

Abstract
background: We review our institutional experience with pediatric laryngomalacia (LM) cases and report our experience in patients undergoing supraglottoplasty using the spontaneous respiration using intravenous anesthesia and high-flow nasal oxygen (STRIVE Hi) technique.
Methods: The medical records of 29 children with LM who visited XX Hospital between January 2017 and March 2019 were retrospectively reviewed. Surgical management was performed using the STRIVE Hi technique. Intraoperative findings and postoperative surgical outcomes, including complications and changes in symptoms and weight, were analyzed.
Results: Of the total study population of 29 subjects, 20 (68.9%) were female. The patients were divided according to the Onley's classification as follows: type I (n = 13, 44.8%), II (n = 10, 34.5%), and III (n = 6, 20.7%). Twenty-five patients (86.2%) had comorbidities. Seventeen patients (58.6%) underwent microlaryngobronchoscopy under STRIVE Hi anesthesia. Four patients with several desaturation events required rescue oxygenation by intermittent intubation and mask bagging during the STRIVE Hi technique. However, the procedure was completed in all patients without any severe adverse effects. Overall, 15 children (51.7%) underwent supraglottoplasty. Among the subjects who underwent supraglottoplasty, 14 (93.3%) showed improvement of symptoms, and their postoperative weight percentile was significantly increased (p = 0.026). One patient required tracheostomy immediately after supraglottoplasty due to associated neurological disease.
Conclusion: The STRIVE Hi technique is feasible for supraglottoplasty in LM patients, while type III LM patients with micrognathia or glossoptosis may have a higher risk of requiring rescue oxygenation during the STRIVE Hi technique.

PMID: 33541038 [PubMed - as supplied by publisher]

View on the web

Chirurgie thyroïdienne avec hypnosédation : à propos de 50 cas

xlomafota13 shared this article with you from Inoreader

1-s2.0-S1879726121X00022-cov150h.gif

Publication date: February 2021

Source: Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale, Volume 138, Issue 1

Author(s): G. Badidi, M. Baulieu, P. Vercherin, V. De Pasquale, M. Gavid, J.M. Prades

View on the web

Planification virtuelle comparée à la conformation manuelle pour les reconstructions mandibulaires par lambeau libre de fibula : étude scannographique de la symétrie

xlomafota13 shared this article with you from Inoreader

1-s2.0-S1879726121X00022-cov150h.gif

Publication date: February 2021

Source: Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale, Volume 138, Issue 1

Author(s): S. Bartier, O. Mazzaschi, L. Benichou, E. Sauvaget

View on the web

Αναζήτηση αυτού του ιστολογίου